Zhang, M., Huang, J., Zheng, X., Huang, P., Yang, X. (2025). Cost-effectiveness analysis of eribulin versus dacarbazine in patients with advanced liposarcoma. Scientific Reports. https://doi.org/10.1038/s41598-024-84247-w